OVID vs ZBRA · rev $733.0K vs P/E 28, rev $3.05B
Ovid Therapeutics Inc (OVID) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.
Latest reported ZBRA revenue for 2026-07-04 was $3.05B. Net income was $368.0M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
OVID currently screens at market cap $23.5M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the OVID and ZBRA stock pages for the full models.
Not investment advice.